Observes the need for revision surgery in patients with uncontrolled CRSwNP despite dupilumab, suggesting a need for new treatments.
Revision endoscopic sinus surgery as an escape-treatment for uncontrolled CRSwNP despite dupilumab is rarely needed. The disappointing results of revision ESS for patients with uncontrolled CRSwNP who failed dupilumab calls for new treatments for this limited group.
No takes yet. Share an insight, caveat, or question.
Kemp et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: